Metabolic monitoring and management among clozapine users

Tso, Grace, Kumar, Puja, Jayasooriya, Thilini, Kisely, Steve and Siskind, Dan (2016) Metabolic monitoring and management among clozapine users. Australasian Psychiatry, 25 1: 48-52. doi:10.1177/1039856216665282


Author Tso, Grace
Kumar, Puja
Jayasooriya, Thilini
Kisely, Steve
Siskind, Dan
Title Metabolic monitoring and management among clozapine users
Journal name Australasian Psychiatry   Check publisher's open access policy
ISSN 1039-8562
1440-1665
Publication date 2016-09-02
Year available 2016
Sub-type Article (original research)
DOI 10.1177/1039856216665282
Open Access Status Not yet assessed
Volume 25
Issue 1
Start page 48
End page 52
Total pages 5
Place of publication London, United Kingdom
Publisher Sage Publications
Language eng
Subject 2738 Psychiatry and Mental health
Abstract Objective: To assess, among clozapine users, the rates of monitoring, presence and treatment of metabolic syndrome and its components. Methods: A chart review was conducted of all clozapine users who were followed up in community mental health clinics at two Metro South Health Hospitals over a 1-year period. Metabolic syndrome was diagnosed according to the International Diabetes Federation criteria. Results: We included 251 clozapine users. Only 43.4% (109/251) had data collected for all five metabolic syndrome parameters. Among these people, 45.0% (49/109) met criteria for metabolic syndrome, while 61.2% (30/49) of those with metabolic syndrome were offered appropriate treatments. Correspondence with primary care providers occurred in only 18.7% (n = 47). Non-pharmacological interventions, such as motivational interviewing and education about healthy lifestyle alternatives, occurred in 49.8% (n = 125). Conclusions: There is growing awareness of the importance of metabolic monitoring, however, there remain specific gaps in the collaborative work among mental health services, primary care providers and clozapine users, to ensure appropriate physical health interventions.
Formatted abstract
Objective: To assess, among clozapine users, the rates of monitoring, presence and treatment of metabolic syndrome and its components.

Methods: A chart review was conducted of all clozapine users who were followed up in community mental health clinics at two Metro South Health Hospitals over a 1-year period. Metabolic syndrome was diagnosed according to the International Diabetes Federation criteria.

Results: We included 251 clozapine users. Only 43.4% (109/251) had data collected for all five metabolic syndrome parameters. Among these people, 45.0% (49/109) met criteria for metabolic syndrome, while 61.2% (30/49) of those with metabolic syndrome were offered appropriate treatments. Correspondence with primary care providers occurred in only 18.7% (n = 47). Non-pharmacological interventions, such as motivational interviewing and education about healthy lifestyle alternatives, occurred in 49.8% (n = 125).

Conclusions: There is growing awareness of the importance of metabolic monitoring, however, there remain specific gaps in the collaborative work among mental health services, primary care providers and clozapine users, to ensure appropriate physical health interventions.
Keyword Metabolic syndrome
Clozapine
Antipsychotic
Psychosis
Metabolic monitoring
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: HERDC Pre-Audit
Admin Only - School of Medicine
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Mon, 05 Sep 2016, 19:39:45 EST by Grace Tso on behalf of Psychiatry - Princess Alexandra Hospital